Nano Drug Delivery Systems for Colon Cancer: Innovations, Challenges, and Applications
Language: English
Published by Academic Press, 2026
- Softcover
- New

Seller: Biblios, frankfurt am main, hessen, GermanyBiblios
AbeBooks seller since September 10, 2024
Condition: New
£ 161.00
Quantity: 3 available
Add to basketSeller Inventory # 18403853300
- Title
- Nano Drug Delivery Systems for Colon Cancer: Innovations, Challenges, and Applications
- Publisher
- Academic Press
- Publication year
- 2026
- Condition
- New
- Binding
- Soft cover
- Language
- English
- ISBN 10
- 0443404437
- ISBN 13
- 9780443404436
It serves as a vital resource, fostering interdisciplinary knowledge and advancements that have the potential to revolutionize colon cancer therapeutics. This book’s interdisciplinary approach ensures it is a beacon of knowledge for those seeking to navigate and innovate within this critical field.
- Delivers an in-depth exploration of the design, synthesis, and application of nanodrug delivery systems
- Unveils groundbreaking and state-of-the-art approaches in colon cancer diagnosis and treatment, placing readers at the cutting edge of medical innovation
- Showcases how strategic design methodologies can dramatically boost therapeutic efficacy, paving the way for more effective colon cancer treatments
"Synopsis" may belong to another edition of this title.
About the Author
Arun Kumar Singh is an Assistant Professor in the Department of Pharmacy at University School of Pharmaceutical Sciences, Rayat Bahra University V.P.O. Sahauran, India. His research interests include nano-formulation, blockchain, IoT, machine learning, artificial intelligence, big data analytics, cancer biology, and neuroscience. He has contributed academic books and book chapters and has published review articles in the areas of pharmaceutical sciences and healthcare technology. His work focuses on interdisciplinary approaches integrating pharmaceutical research with emerging digital and computational technologies.
Dr. Vipan Kumar is an Associate Professor at the School of Pharmaceutical Sciences, CGC University, Mohali, India. He received his PhD in Pharmaceutical Sciences from Maharshi Dayanand University, Rohtak, India, where he was awarded fellowship support from the University Grants Commission (UGC), New Delhi. Dr. Kumar’s research focuses on medicinal chemistry, nanotechnology-based drug delivery, and the development of novel therapeutic agents for cancer and metabolic disorders. Dr. Kumar has published over 35 research and review articles in peer-reviewed national and international journals and has authored and edited 04 national and international books, along with several book chapters. He also holds 04 Indian patents in the areas of drug discovery and nanomedicine. His academic achievements have been recognized with several honors, including the Backbone Award (2025–26) from CGC University, Mohali, and the Devi Lal Memorial Award (2020–21) from JCD Vidyapeeth, Sirsa, for excellence in teaching and research. Dr. Kumar serves on the editorial boards of multiple international journals and acts as a reviewer for several reputed publications. He has delivered more than 30 oral and poster presentations at national and international scientific meetings and actively contributes to academic governance and policy development through his roles in ethical committees, inspection teams, examination committees, and university Boards of Studies.
Pranav Kumar Prabhakar is Professor and Head of the Department of Biotechnology, School of Engineering and Technology, Nagaland University, Kohima, India. His research focuses on understanding molecular mechanisms involved in metabolic disorders, particularly diabetes, and on developing strategies for oral insulin delivery using natural products and biotechnology-based approaches. He is actively involved in research, academic mentoring, peer review, and editorial activities within the biomedical and biotechnology fields. His professional interests include translational research, signaling pathways associated with metabolic diseases, and the application of biotechnology to improve therapeutic outcomes. He contributes to scientific and academic initiatives that support advancements in biotechnology and healthcare research.
Dr. Meenakshi Dhanawat is an Associate Professor at the Amity Institute of Pharmacy, Amity University Haryana, with many years of experience in Pharmaceutical Sciences and Medicinal Chemistry. She completed her Master's degree at NIPER, Mohali, focusing on glycosylamino acids, and earned her Ph.D. from IIT-BHU, Varanasi, investigating CNS drug delivery targeting 5HT1A/2A receptors. Her research encompasses synthetic and heterocyclic chemistry, nanotechnology, drug delivery systems, prodrug design, complexation, polymer chemistry, and herbal drug extraction. Dr. Dhanawat has received notable international recognition, including a travel grant from the AAPS Drug Delivery and Development section for the 2010 National Biotechnology Conference in California, and international travel grants from DBT and DST, Government of India, for conferences in California and Munich. Her distinguished honors include the Rajiv Gandhi National Fellowship, affirming her sustained contributions to pharmaceutical research and academic excellence.
Neeraj Mishra is Professor and Head of the Department of Pharmaceutics at the Amity Institute of Pharmacy, Amity University Madhya Pradesh, Gwalior, India. His academic work focuses on novel drug delivery systems, including localized, targeted, and controlled delivery approaches using nanocarrier and microparticle-based technologies. His research interests encompass therapies for cancer and neurodegenerative disorders, and he has extensive experience in teaching, research supervision, and scholarly publishing. He has also contributed to innovation in pharmaceutical sciences through intellectual property development and collaborative academic activities. Through his research and educational initiatives, he supports the advancement of drug delivery strategies and pharmaceutical research.
"About the title" may belong to another edition of this title.
Biblios
frankfurt am main, hessen, Germany
AbeBooks seller since September 10, 2024
Shipping rates from Germany to U.S.A.
| Item | 25 to 45 business days | 8 to 14 business days |
|---|---|---|
| First item | £ 8.30 | £ 15.60 |
Payment methods
Store description
We carry a wide selection of books from South Asia, United States, UK.
Specialty
new books imported from india, uk, usaSeller's business information
Readingos GmbH
Kaiserstraße 47
Frankfurt am Main, Germany 60329
We ship from Frankfurt
Right of withdrawal
If you are a consumer you can withdraw from the contract in accordance with the following. Consumer means any natural person who is acting for purposes which are outside his trade, business, craft or profession.
Information regarding the right of withdrawal
Statutory right to withdraw
You have the right to withdraw from this contract within 14 days without giving any reason.
The withdrawal period will expire after 14 days from the day on which you acquire, or a third party other than the carrier and indicated by you acquires, physical possession of the last good or the last lot or piece.
To exercise the right of withdrawal, electronically fill in and submit a clear statement on our website, under "My Purchases" in "My Account". We will communicate to you an acknowledgement of receipt of such a withdrawal on a durable medium (e.g. by e-mail) without delay.
To meet the withdrawal deadline, it is sufficient for you to send your communication concerning your exercise of the right of withdrawal before the withdrawal period has expired.
Effects of withdrawal
If you withdraw from this contract, we will reimburse to you all payments received from you, including the costs of delivery (except for the supplementary costs arising if you chose a type of delivery other than the least expensive type of standard delivery offered by us).
We may make a deduction from the reimbursement for loss in value of any goods supplied, if the loss is the result of unnecessary handling by you.
We will make the reimbursement without undue delay, and not later than 14 days after the day on which we are informed about your decision to withdraw from this contract.
We will make the reimbursement using the same means of payment as you used for the initial transaction, unless you have expressly agreed otherwise; in any event, you will not incur any fees as a result of such reimbursement.
We may withhold reimbursement until we have received the goods back, or you have supplied evidence of having sent back the goods, whichever is the earliest.
You shall send back the goods or hand them over to Biblios, frankfurt am main, Germany, without undue delay and in any event not later than 14 days from the day on which you communicate your withdrawal from this contract to us. The deadline is met if you send back the goods before the period of 14 days has expired. You will have to bear the direct cost of returning the goods. You are only liable for any diminished value of the goods resulting from the handling other than what is necessary to establish the nature, characteristics and functioning of the goods.
Exceptions to the right of withdrawal
The right of withdrawal does not apply to:
- The delivery of newspapers, journals or magazines with the exception of subscription contracts; and
- The supply of digital content which is not supplied on a tangible medium (e.g. on a CD or DVD) if you accepted when you placed your order that we could start to deliver it, and that you could not withdraw once delivery had started.